Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 12, 2014, Pages 1368-1375

  Sebag, Frederic A ^a   Lellouche, Nicolas ^a   Chen, Zhong ^b   Tritar, Amine ^a   O'Neill, Mark D ^b   Gill, Jaswinder ^b   Wright, Matthew ^b   Leclercq, Christophe ^c   Rinaldi, Christopher A ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

cardiac resynchronization therapy; heart failure; implantable cardioverter defibrillator; remodeling; sudden death; ventricular arrhythmia

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEVICE INFECTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEAD FRACTURE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSTHORACIC ECHOCARDIOGRAPHY; ARRHYTHMIAS, CARDIAC; CLINICAL TRIAL; COMPLICATION; FRANCE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PROCEDURES; TREATMENT OUTCOME; UNITED KINGDOM;

AGED; ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FRANCE; GREAT BRITAIN; HEART FAILURE; HUMANS; MALE; PRIMARY PREVENTION; TREATMENT OUTCOME;

EID: 84926335907     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12496     Document Type: Article

References (41)

1. Dickstein K, Vardas PE, Auricchio A, Daubert J-C, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Tendera M, Anker SD, Blanc J-J, Gasparini M, Hoes AW, Israel CW, Kalarus Z, Merkely B, Swedberg K, Camm AJ,: 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 2010; 12: 1526-1536.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M,: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-1940.
4. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
5. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C,: Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008; 52: 1834-1843.
6. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NAM III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W,: Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
7. Ouellet G, Huang DT, Moss AJ, Hall WJ, Barsheshet A, McNitt S, Klein H, Zareba W, Goldenberg I,: Effect of cardiac resynchronization therapy on the risk of first and recurrent ventricular tachyarrhythmic events in MADIT-CRT. J Am Coll Cardiol 2012; 60: 1809-1816.
8. Garrigue S, Barold SS, Hocini M, Jaïs P, Haïssaguerre M, Clementy J,: Treatment of drug refractory ventricular tachycardia by biventricular pacing. Pacing Clin Electrophysiol PACE 2000; 23: 1700-1702.
9. Walker S, Levy TM, Rex S, Brant S, Allen J, Ilsley CJ, Paul VE,: Usefulness of suppression of ventricular arrhythmia by biventricular pacing in severe congestive cardiac failure. Am J Cardiol 2000; 86: 231-233.
10. Shukla G, Chaudhry GM, Orlov M, Hoffmeister P, Haffajee C,: Potential proarrhythmic effect of biventricular pacing: Fact or myth? Heart Rhythm 2005; 2: 951-956.
11. Medina-Ravell VA, Lankipalli RS, Yan G-X, Antzelevitch C, Medina-Malpica NA, Medina-Malpica OA, Droogan C, Kowey PR,: Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 2003; 107: 740-746.
12. Guerra JM, Wu J, Miller JM, Groh WJ,: Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol 2003; 14: 1245-1247.
13. Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG,: Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2005; 46: 2258-2263.
14. Gold MR, Linde C, Abraham WT, Gardiwal A, Daubert J-C,: The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure. Heart Rhythm 2011; 8: 679-684.
15. Chen Z, Hanson B, Sohal M, Sammut E, Child N, Shetty A, Boucher R, Bostock J, Gill J, Carr-White G, Rinaldi CA, Taggart P,: Left ventricular epicardial electrograms show divergent changes in action potential duration in responders and nonresponders to cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2013; 6: 265-271.
16. Hauser RG,: The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol 2005; 45: 2022-2025.
17. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD,; Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group: Long-term clinical course of patients after termination of ventricular tachy-arrhythmia by an implanted defibrillator. Circulation 2004; 110: 3760-3765.
18. Borleffs CJW, van Rees JB, van Welsenes GH, van der Velde ET, van Erven L, Bax JJ, Schalij MJ,: Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010; 55: 879-885.
19. Botto GL, Dicandia CD, Mantica M, La Rosa C, D'Onofrio A, Bongiorni MG, Molon G, Verlato R, Villani GQ, Scaccia A, Raciti G, Occhetta E,: Clinical characteristics, mortality, cardiac hospitalization, and ventricular arrhythmias in patients undergoing CRT-D implantation: Results of the ACTION-HF study. J Cardiovasc Electrophysiol 2013; 24: 173-181.
20. van Welsenes GH, van Rees JB, Thijssen J, Trines SA, van Erven L, Schalij MJ, Borleffs CJW,: Primary prevention implantable cardioverter defibrillator recipients: The need for defibrillator back-up after an event-free first battery service-life. J Cardiovasc Electrophysiol 2011; 22: 1346-1350.
21. Auricchio A, Prinzen FW,: Non-responders to cardiac resynchronization therapy: The magnitude of the problem and the issues. Circ J 2011; 75: 521-527.
22. Gasparini M, Auricchio A, Metra M, Regoli F, Fantoni C, Lamp B, Curnis A, Vogt J, Klersy C,; Multicentre Longitudinal Observational Study (MILOS) Group: Long-term survival in patients undergoing cardiac resynchronization therapy: The importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 2008; 29: 1644-1652.
23. Ypenburg C, van Bommel RJ, Borleffs CJW, Bleeker GB, Boersma E, Schalij MJ, Bax JJ,: Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009; 53: 483-490.
24. Rickard J, Kumbhani DJ, Popovic Z, Verhaert D, Manne M, Sraow D, Baranowski B, Martin DO, Lindsay BD, Grimm RA, Wilkoff BL, Tchou P,: Characterization of super-response to cardiac resynchronization therapy. Heart Rhythm 2010; 7: 885-889.
25. Pouleur A-C, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, McNitt S, Hall WJ, Zareba W, Goldenberg I, Moss AJ, Pfeffer MA, Solomon SD,: Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: The MADIT-CRT trial. Eur Heart J 2011; 32: 1720-1729.
26. Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, Daubert C,; REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group: Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Eur Heart J 2013; 34: 2592-2599.
27. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, Powe NR,: Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials. J Am Med Assoc 2003; 289: 730-740.
28. Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG,: Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2005; 46: 2258-2263.
29. Schliamser JE, Kadish AH, Subacius H, Shalaby A, Schaechter A, Levine J, Goldberger JJ,; DEFINITE Investigators: Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE). Heart Rhythm 2013; 10: 838-846.
30. Manfredi JA, Al-Khatib SM, Shaw LK, Thomas L, Fogel RI, Padanilam B, Rardon D, Vatthyam R, Gemma LW, Golden K, Prystowsky EN,: Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias. Circ Arrhythm Electrophysiol 2013; 6: 257-264.
31. Gorgels APM, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens HJJ,: Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 2003; 24: 1204-1209.
32. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Mäkikallio TH, Juhani Airaksinen KE, Myerburg RJ,: Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003; 42: 652-658.
33. Aljaroudi WA, Flamm SD, Saliba W, Wilkoff BL, Kwon D,: Role of CMR imaging in risk stratification for sudden cardiac death. JACC Cardiovasc Imaging 2013; 6: 392-406.
34. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ,: Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-484.
35. Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, Noullett C, Van Schaik A, Mitchell RT, Shibata MA, Gulamhussein S, McMeekin J, Tymchak W, Schnell G, Gillis AM, Sheldon RS, Fick GH, Duff HJ,; REFINE Investigators: Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 2007; 50: 2275-2284.
36. Borleffs CJW, van Erven L, Schotman M, Boersma E, Kiès P, van der Burg AEB, Zeppenfeld K, Bootsma M, van der Wall EE, Bax JJ, Schalij MJ,: Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: Long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT). Eur Heart J 2009; 30: 1621-1626.
37. Marcus GM, Rose E, Viloria EM, Schafer J, De Marco T, Saxon LA, Foster E,; VENTAK CHF/CONTAK-CD Biventricular Pacing Study Investigators: Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 2005; 46: 2208-2214.
38. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, Leõn AR, Oshinski JN,: Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 2010; 121: 1985-1991.
39. Molhoek SG, van Erven L, Bootsma M, Steendijk P, van Der Wall EE, Schalij MJ,: QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure. Pacing Clin Electrophysiol PACE 2004; 27: 308-313.
40. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A,; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators: Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006; 113: 776-782.
41. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NAM III, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W,; MADIT-RIT Trial Investigators: Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367: 2275-2283.